MedMira Inc.
MMIRF · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $174 | $413 | $433 | $952 |
| % Growth | -57.9% | -4.6% | -54.6% | – |
| Cost of Goods Sold | $888 | $186 | $132 | $648 |
| Gross Profit | -$715 | $226 | $300 | $304 |
| % Margin | -411.7% | 54.9% | 69.4% | 31.9% |
| R&D Expenses | $946 | $477 | $471 | $191 |
| G&A Expenses | $1,267 | $1,196 | $843 | $735 |
| SG&A Expenses | $793 | $1,479 | $1,039 | $750 |
| Sales & Mktg Exp. | $339 | $283 | $196 | $15 |
| Other Operating Expenses | $0 | $843 | $735 | $0 |
| Operating Expenses | $1,739 | $2,799 | $2,245 | $1,574 |
| Operating Income | -$3,590 | -$2,573 | -$1,944 | -$1,453 |
| % Margin | -2,067.9% | -623.7% | -449.5% | -152.6% |
| Other Income/Exp. Net | -$935 | -$753 | -$731 | -$378 |
| Pre-Tax Income | -$4,524 | -$3,326 | -$2,676 | -$1,832 |
| Tax Expense | $0 | $0 | $0 | $174 |
| Net Income | -$3,266 | -$3,326 | -$2,676 | -$1,832 |
| % Margin | -1,881.2% | -806.2% | -618.6% | -192.4% |
| EPS | -0.005 | -0.005 | -0.004 | -0.003 |
| % Growth | 2.1% | -20% | -48.1% | – |
| EPS Diluted | -0.005 | -0.005 | -0.004 | -0.003 |
| Weighted Avg Shares Out | 697,666 | 697,666 | 668,915 | 680,646 |
| Weighted Avg Shares Out Dil | 697,666 | 697,666 | 697,446 | 680,646 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$14 | $886 | $552 |
| Interest Expense | $777 | $882 | $0 | $552 |
| Depreciation & Amortization | $229 | $310 | $213 | $212 |
| EBITDA | -$2,259 | -$2,134 | -$1,577 | -$1,067 |
| % Margin | -1,301.5% | -517.3% | -364.7% | -112.1% |